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Abstract 
BACKGROUND: The primary reason for poor adverse drug reaction (ADR) signal detection worldwide is the 
under-reporting of ADRs by healthcare professionals. Multidisciplinary teams, including pharmacists, may play an 
essential role in targeting this issue. 
AIM: The purpose of the study was to evaluate the impact of a multi-faceted educational intervention (MEI) on the 
knowledge, perception, and practice skills of pharmacovigilance among undergraduate pharmacy students. 
METHODS: A longitudinal, prospective study using a single group before-and-after intervention design was 
conducted among 100 undergraduate pharmacy students at Togari Veeramallappa Memorial College of 
Pharmacy, Ballari, India (TVMCP), affiliated to Vijayanagara Institute of Medical Sciences (VIMS), Ballari, India. 
The questionnaire was structured using previous studies and standardized. It had three groups of questions. 
Group 1 questions evaluated the knowledge (K1-K8), group 2 tested perceptions (A1-A6), and group 3 tested the 
practice skills of pharmacovigilance (P1-P5) of the participant. The participants were graded in 3 categories as 
poor, unsatisfactory, and satisfactory, depending upon the mean score. Matched pairs student t-test and The 
Wilcoxon Signed rank statistical test was used to assess the impact of the MEI on the participants' knowledge, 
perception, and practice skills score, along with recording different factors preventing them from being actively 
involved in the pharmacovigilance program. 
RESULTS: The educational intervention improved the pharmacovigilance knowledge, perception, and practice 
skills scores of our pharmacy students. 
CONCLUSION: Our study showed that knowledge, perception, and practice skills scores increased after MEI 
highlighting the need for regular educational campaigns to healthcare professions. 
 
 
 
Introduction 
 
Pharmacovigilance (PV) is the scientific 
activity related to the monitoring of adverse drug 
reactions (ADR), including any other drug-related 
problem [1]. The National Pharmacovigilance Program 
of India (PvPI) is the governmental authority that 
directs all activities of ADR detection, their 
assessment, understanding, and prevention, along 
with submission of drug safety reports to the World 
Health Organisation-ADR monitoring center located at 
Uppsala, Sweden [2]. There are around 60,000–
80,000 different drug brands obtainable in market of 
India which are frequently irrationally prescribed and 
mistreated that could be due to deficient medicine 
safety usages, and lack of robust governing 
environment [3]. The incorrect prescribing and misuse 
account for a substantial increase in adverse drug 
reactions (ADRs), which are the principal reasons for 
unplanned hospitalization, morbidity, fatality, and 
raised health-care expenses worldwide [4], [5]. 
Therefore, for assuring the patient's well-being, this is 
a call of the hour to recognize ADRs and if practicable 
prevent them, at a sensible cost. 
Spontaneous or voluntary reporting of 
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suspected ADRs to pharmacovigilance centers by 
health-care professionals is the cornerstone of 
pharmacovigilance [6], which requires a multi-
disciplinary strategy, wherein different health-care 
professionals, including medicine, pharmacy, 
dentistry, and nursing have to make a significant 
contribution. This preventable characteristic of 
adverse drug reactions is the motive for contemporary 
ADR reporting programs, which reinforce the 
significance of immediate identification and their 
treatment [7]. Anticipating, recognizing, effective 
management, and reporting ADRs are also an 
essential component of rational and unharmed 
prescribing, that are integrated into discrete steps of 
the WHO-six-step Guide to Good Prescribing [8]. 
Indeed, lower reporting of suspected and 
even confirmed ADRs by all health-care professionals 
is a massive obstacle in India [9]. Due to limitations of 
efficient healthcare support in low- and intermediate-
income countries like India, due to shorter contact 
time interval between practitioners and patients, 
absence of complete data in patients' reports about 
safety of drugs and also need of time to notify drug-
related problems, the performance of reporting the 
ADRs must be distributed amongst trained health-care 
professionals including pharmacists and nurses [10] to 
check underreporting [11]. Community pharmacists 
are thus in a unique position for monitoring, reporting 
of ADRs, management of symptoms associated with 
ADRs due to their easy accessibility for patients. 
Moreover, by addressing appropriate counseling of 
medications for the patients, they play the main role in 
preventing ADRs [12]. Most pharmacy students start 
the clinical practice soon after graduation, and 
therefore they dispense and monitor drugs daily. To 
execute these responsibilities efficiently as one of the 
sections of the health-care team and to ensure the 
safe usage of medications, they should obtain at least 
some standard pharmacovigilance competencies 
before they certify and commence clinical practice 
[13]. Based on these considerations, the present 
research was conducted to evaluate the knowledge, 
perceived behavior, and practice skills towards 
pharmacovigilance amongst undergraduate pharmacy 
students to highlight any existing gaps and result of 
multifaceted educational intervention on their 
knowledge, perception, and practice skills for the PV 
programme. 
Aim of the study: Assessment of the 
knowledge, perceived behavior, and practice skills 
toward pharmacovigilance and influence of the multi-
faceted educational intervention (MEI) on their 
knowledge, perception and practice skills for the PV 
programme among undergraduate pharmacy students 
of India. 
Specific Objectives: 1) To evaluate the 
knowledge related to Pharmacovigilance among 
undergraduate pharmacy students; 2) To assess the 
perceived behavior towards Pharmacovigilance 
among undergraduate pharmacy students; 3) To 
assess practice skills related to Pharmacovigilance 
among undergraduate pharmacy students; and 4) To 
determine the efficiency of multi-faceted educational 
intervention on pharmacy students’ knowledge status, 
perception, and practice skills for ADR reporting 
requirements by comparing before and after the 
intervention. 
 
 
Materials and Methods 
 
Design of the study: A longitudinal, 
prospective study using a single group was conducted 
from February 2016 through May 2016 in form of 
before and after multi-faceted educational intervention 
design measuring the achievement of respondents 
after training session to evaluate the intervention’s 
outcome [14]. 
The Study Setting: The study was carried at 
Togari Veeramallappa Memorial College of Pharmacy 
(TVMCP), Ballari affiliated to Vijayanagara Institute of 
Medical Sciences (VIMS), Ballari, Karnataka. The 
students have regular clinical postings at the hospital 
of VIMS. The ethical permission from Institutional 
Review Board of the institution was obtained before 
the start of the study. 
 
Sample selection criteria 
Inclusion criteria: The non-probability 
convenience sample of the undergraduate pharmacy 
students which were studying pre-final and final year 
of B. Pharmacy, Pharm. D (Doctor of Pharmacy) and 
final year D. pharm. at Togari Veeramallappa 
Memorial College of Pharmacy, Ballari (TVMCP) who 
gave their informed consent were included in our 
study. 
Exclusion criteria: Participants who do not 
give their consent were not included in the study. 
Sample size calculation: The sample size for 
the study was calculated after going through a 
selection of literature on various studies about 
pharmacovigilance and their perceptions [15]. Using G 
* power sample size calculator with a power of 80% 
and 5% α-error, a sample size of 100 subjects was 
required for detecting an effect size of 0.25 between 
pairs indicating a 25% frequency difference. 
 
Study Tool Development 
The data was collected using a validated 
questionnaire. Detailed review of relevant literature 
was done to develop the instrument acccording to its 
purpose and all constructs of interest [16], [17], [18]. 
The questionnaire was examined for its face and 
content validity by two independent faculty members 
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from the college of pharmacy regarding the relevance, 
clarity, conciseness of the items, and ease of 
understanding of the questions. However, a pilot study 
was carried out in 20 students of the first year of 
pharmacy students determining the reliability of the 
questionnaire and, if required, further simplification of 
the language and validation of the tool was done. It 
composed of four parts: Section I comprised 
demographic information. Section II related to eight 
knowledge assessment questions designed with 
multiple-choice options, Section III, focused on 
perceptive behavior, and their attitudes and section IV 
consisted of an evaluation of the practical skills for 
ADR reporting. A score of one was credited to the 
right answer and zero score to the wrong answer. 
Lastly, the causes that hinder them from active 
participation in the pharmacovigilance program were 
too recorded. The participants were graded in 3 
categories as poor, unsatisfactory and satisfactory 
depending upon the mean score as shown in Table 1. 
Table 1: Knowledge, perception, and practice skills of the 
pharmacovigilance score range 
Parameter  Poor Unsatisfactory Satisfactory Max score 
Knowledge 1-2 3-4 5-8 8 
Perception 1-2 3 4-6 6 
Practice skills 1-2 3 4-5 5 
 
Data collection and Multifaceted 
 educational intervention 
The study was carried from February 2016 
through May 2016 among 100 undergraduate 
pharmacy students studying pre-final and final year of 
B. Pharmacy, Pharm. D (Doctor of Pharmacy), and 
final year D. pharm. at Togari Veeramallappa 
Memorial College of Pharmacy, Ballari. Pagotto C et 
al., first suggested the applied multi-faceted 
educational interventional (MEI) model. Briefly, the 
MEI involved four different sessions, each lasting one 
hour [19]. During the first session, the structured 
questionnaire was used to obtain baseline information 
about the students' knowledge, perception, and 
practice skills associated with pharmacovigilance and 
therefore called the pre-educational evaluation. It was 
followed by second and third sessions involving a 
lecture on pharmacovigilance concepts and its 
importance and a practical class on how to accurately 
fill up ADR reports and the distribution of educational 
material to the participating students. The post-
educational assessment was carried out in the final 
session. The participators were requested to fill out 
the same questionnaire, which they finished at the 
time of the first session to facilitate an evaluation of 
the effectiveness of the interference on their 
knowledge, perception, and practice skills of 
pharmacovigilance. 
 
Data analysis 
The data was interpreted using the statistical 
software JMP®, Version 12, SAS Institute Inc., Cary, 
NC, 1989-2019. Descriptive statistics were conducted 
to estimate the KAP score of the participant and 
between sexes. Matched pairs student-t-test and the 
Wilcoxon Signed rank statistical test was applied to 
assess the influence of the MEI on the participants’ 
knowledge, perception, and practice skills score. The 
statistical significance was fixed at a p-value of 0.05 
and a 95% confidence interval. 
 
 
Results 
 
Figures 1 show descriptive statistics indicating 
the pre and post-intervention knowledge, perception 
and practice skills score of pharmacovigilance among 
study participants where the respondents are graded 
in 3 categories as poor, unsatisfactory, and 
satisfactory depending upon the mean score. 
 
 
 
Figure 1: Comparison of pre and post-intervention knowledge score 
of pharmacovigilance among students (top); Comparison of pre and 
post-intervention perception score of pharmacovigilance among 
students (middle); Comparison of pre and post-intervention Practice 
skills score of pharmacovigilance among students (bottom) 
 
Figure 2 and Table 2 depicts the effect of 
educational intervention as Matched Pairs Difference 
of knowledge post-intervention score-knowledge pre-
intervention score that is statistically significant with a 
p-value of < 0.0001*, that is confirmed with Wilcoxon-
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Signed Rank statistical test in Table 3. 
 
Figure 2: Matched Pairs Difference: Knowledge post-intervention 
score-Knowledge Pre-intervention score 
 
Figure 3 and Table 4 depicts the impact of 
educational intervention as Matched Pairs Difference 
test of perception post-intervention score-knowledge 
pre-intervention score that is statistically significant 
with a p-value of < 0.0001*, that is confirmed with 
Wilcoxon-Signed Rank statistical test in Table 3. 
Table 2: Matched Pairs Difference: Knowledge post-
intervention score-Knowledge Pre-intervention score 
Knowledge post-intervention score 5.94 t-Ratio 16.33071 
Knowledge Pre-intervention score 2.2 DF 99 
Mean Difference 3.74 Prob > |t| < 0.0001* 
Std Error 0.22902 Prob > t < 0.0001* 
Upper 95% 4.19442 Prob < t 1.0000 
Lower 95% 3.28558   
N 100   
 
Figure 4 and Table 5 depicts the Matched 
Pairs Difference test of practice skills post-intervention 
score- practice skills pre-intervention score that is 
statistically significant with a p-value of < 0.0001* and 
confirmed with non-parametric Wilcoxon-Signed Rank 
statistical test in Table 3. 
Table 3: Wilcoxon Signed-Rank of the parameters 
  
Knowledge post-
score-Knowledge pre 
score 
Perception post-score-
Perception pre Score 
Practice skills post 
score-Practice skills pre 
Score 
Test Statistic S 2435.50 1469.00 2045.00 
Prob > S < 0.0001* < 0.0001* < 0.0001* 
Prob < S 1.0000 1.0000 1.0000 
 
 
 
Discussion 
 
India contributed more than 1,00,000 
Individual Case Safety Reports (ICSRs) in the 
Vigibase which is World Health Organisation (WHO)-
Uppsala Monitoring Centre's global drug safety 
database. Between the period April 2011 and March 
2016, the National Coordination Centre- 
Pharmacovigilance Programme of India (NCC-PvPI) 
received a total of 1,81,656 reports from different 
sources, like registered ADR monitoring centres 
(AMCs), Non-AMC and via Toll-free helpline number 
[20]. However, the contribution from India towards 
ADR reporting is below 1%, which highlights the 
existent gaps in the progress of the PV program. With 
regard to the source of reports, during period between 
April 2015 – March 2016, a total of 63,970 reports 
received nationally, the physicians (56%) were a 
prominent source, followed by the other health-care 
professionals (19%). The pharmacists comprised only 
13% of reporters followed by consumers or other non-
healthcare professionals (12%) [20]. 
 
Figure 3: Matched Pairs Difference of Perception post-intervention 
score-Perception Pre-intervention Score 
 
Certainly, recognizing the significance of 
reporting the ADRs, it is recommended that health-
care professionals prioritize timely reporting of ADRs 
to decrease ADR related problems. A systematic 
review proposes that inter-professional collaborations 
enhance benefits to health-care assistance and 
improve patient outcomes [21]. Thus, in this study, we 
estimated the knowledge, perception, and practice 
skills of pharmacovigilance amongst undergraduate 
students of pharmacy. 
Table 4: Matched Pairs Difference of Perception post-
intervention score-Perception Pre-intervention Score 
Perception Post-intervention score 4.55 t-Ratio 5.696118 
Perception Pre-intervention Score 3.79 DF 99 
Mean Difference 0.76 Prob > |t| < 0.0001* 
Std Error 0.13342 Prob > t < 0.0001* 
Upper 95% 1.02474 Prob < t 1.0000 
Lower 95% 0.49526   
N 100   
 
The mean knowledge score of our study 
participants before the educational intervention was 
2.2. About 30% and 64% of participants' knowledge 
towards PV was found to be poor and unsatisfactory, 
respectively, as shown in Figure 1. About 59% of 
participants were unaware of the term 
pharmacovigilance, and only 22% knew the definition 
of PV. Comparable findings were seen in previous 
studies, where most utmost health-care professionals 
reported poor knowledge regarding 
pharmacovigilance [22], [23], [24]. 
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Figure 4: Matched Pairs Difference of PV Practice skills Post-
intervention score-Practice skills Pre-intervention Score 
 
Table 6 shows responses to several 
knowledge related questions given pre-intervention 
and post-intervention. Their knowledge had improved 
significantly after educational intervention with raise to 
mean knowledge score of 5.94 out of maximum 8 (< 
0.001). 
Table 5: Matched Pairs Difference of PV Practice skills Post-
intervention score-Practice skills Pre-intervention Score 
Practice skills Post-intervention score 3.61 t-Ratio 9.835285 
Practice skills Pre-intervention Score 2.01 DF 99 
Mean Difference 1.6 Prob > |t| < .0001* 
Std Error 0.16268 Prob > t < .0001* 
Upper 95% 1.92279 Prob < t 1.0000 
Lower 95% 1.27721   
N 100   
 
 The mean perception score before the 
educational intervention was found to be 3.79. About 
58% of participants' perception score towards PV 
reporting was satisfactory. Therefore it showed a 
positive opinion towards the engagement of reporting 
ADRs pre-educational session, as shown in Figure 2.  
Table 6: Knowledge related responses of pharmacovigilance 
from study participants 
Question Correct response 
Pharmacy students 
Pre-
intervention 
% 
Post-
intervention 
% 
Do you know the term 
"Pharmacovigilance"? 
Yes 41% 95% 
Pharmacovigilance is defined as 
Activity of detection, 
assessment, 
understanding, and 
prevention of ADRs 
22% 71% 
The aim of pharmacovigilance is 
to assess 
Safety over efficacy 70% 76% 
Pharmacovigilance include 
Drug, blood, herbal, 
vaccines, and medical 
devices related ADRs 
reporting 
26% 70% 
The Pharmacovigilance Program 
of India was officially launched in 
the year 
2010 23% 69% 
The international center for ADR 
monitoring is located in 
Sweden 17% 76% 
Which of the following is the 
“WHO online databases” for 
reporting ADRs? 
Vigibase 14% 65% 
There are how many ADR 
Monitoring Centres in India? 
179 7% 72% 
 
This was similar with the study of J. Jose et al 
which exhibited a good attitude of pharmacists for 
ADR reporting by good total median attitude score 
and by the research conducted in Saudi Arabia [25], 
[26]. 
Most of our respondents considered that 
reporting of ADRs is necessary (91%) and 81% were 
of positive impression about having ADR monitoring 
centre in every hospital before intervention as 
depicted in Table 7. The educational session resulted 
in additional significant improvement in health-care 
perception with raise to a mean perception score of 
4.55 out of maximum 6. (< 0.001). A majority agreed 
(68%) that non-medical person is allowed to report 
ADR. 
Table 7: Attitude related responses of pharmacovigilance from 
study participants 
Questions 
Correct 
Answer 
Pre-intervention 
% 
Post-
intervention % 
Your view about establishing an ADR 
monitoring center in each hospital? 
Need to be 
in all 
hospitals 
81% 82% 
Do you believe reporting of ADRs is 
necessary? 
Yes 91% 97% 
Do you think pharmacovigilance (PV) 
should be explained in detail to healthcare 
professionals? 
Yes 87% 93% 
Have you come across tutorial sessions in 
specifically about PV? 
Yes 27% 79% 
Have you come across any article on 
prevention of ADRs? 
Yes 40% 48% 
The non-medical person can report ADR to 
nearby healthcare professional? 
Yes 42% 68% 
 
The mean practice skills score before the 
educational intervention was found to be 2.01, and the 
majority were on the poor scale. Only 13% were 
aware of the most common causality assessment 
scale, Naranjo scale, for ADRs. This finding is similar 
to the research of Rajiah K et al., [27] and Gamil Q. 
Othman et al., [28]. A large number of participants did 
not know how to diagnose augmented ADRs. Table 8 
shows answers to various practice skills related 
questions given pre and post-intervention. The 
educational intervention produced a significant 
increase in their practice skills with raise to mean 
practice skills score to 3.61 out of maximum 5 (< 
0.001). 
Table 8: Practice related responses of pharmacovigilance from 
study participants 
 Question Correct Response 
Pre-
intervention 
% 
Post-
intervention 
% 
Which of the method is ordinarily 
implied by pharmaceutical 
corporations for PV of novel drugs 
after they are released in the 
market? 
Post-marketing 
surveillance studies 
54% 70% 
ADR reporting can be done by 
All are correct (Doctors, 
Nurses, Pharmacists) 
24% 69% 
Augmented drug reaction is 
Dose-dependent, 
common in occurrence, 
rarely fatal 
44% 75% 
Which scale is most commonly 
used to determine the causality of 
an ADR? 
Naranjo algorithm 13% 73% 
Elements which are mandatory to 
record 
All ( Identifiable patient, 
reporter, and 
suspected medicinal 
products) 
66% 74% 
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Prior studies reported comparable findings 
showing that coaching health-care professionals 
regarding pharmacovigilance presented with a 
beneficial impact on their knowledge, perception, and 
practice scores (p-value < 0.001) [29], [30]. Another 
study carried out in India revealed that consultants 
who attended continuous medical education (CME) of 
PV determined better information of the ADRs 
reporting method than those who did not participate 
[31]. Accordingly, pharmacy students stressed the 
need for preparing them about PV, ADRs, and how to 
tackle the reporting process. 
Before the educational session, the factors 
discouraging students from taking part in 
pharmacovigilance were asked. The more significant 
number of participants said that they are concerned 
about patient confidentiality, a lack of knowledge on 
the procedure of reporting, and difficulty in diagnosing 
ADR as depicted in Figure 5.  
These determinants should be approached 
and efficiently answered during training programs. 
Furthermore, several obstacles found in the research 
carried amongst pharmacists of Canada and Kingdom 
of Saudi Arabia, that restrict from reporting ADR 
included untold address, reporting form unavailable, 
no knowledge how to communicate (41.7%) and 
doubt towards the causal relationship between ADR 
and the drug (30.1%) [25], [32]. 
 
Figure 5: Factors affecting participation in PV program 
 
Our findings contribute a reason to enhance 
educational campaigns and awareness of 
pharmacovigilance to improve ADR reporting. 
Pharmacovigilance should be part of the educational 
program for undergraduate medical, nursing, 
pharmacy curriculum and other health-care related to 
secure well-prepared graduates in future practice. 
They should be familiarized with the ADR reporting 
and the ways for determining the causality and the 
severity of ADRs by postings in the 
pharmacovigilance centres during studies. 
Frequently, the pharmacist is in a unique 
position and plays more essential roles that include 
many pharmaceutical care aspects, such as evading 
medication errors and ADRs, promoting better Quality 
of Life (QoL), financial outcomes, and patient well-
being. Varallo FR et al., study indicated that using 
MEIs with multidisciplinary teams including 
pharmacists for pharmacovigilance revealed a 
remarkable rise exceeding 100% in the absolute 
number of reports of drug-induced issues, increase in 
the prevalence of medication error reporting and 
increased the relevance of ADE reports [33]. It 
highlighted the importance of adopting a 
multidisciplinary perspective of approach for the 
importance of pharmacovigilance in adding to patient 
safety. Pharmacist participation, therefore, can 
considerably help overcome of underreporting of 
ADRs [34]. 
Other measures would be providing 
incentives to promote the reports on ADRs. As 'lack of 
financial incentives' and lack of time are also the 
reasons for the lower reporting of ADRs by health-
care professionals [35]. The simplification of the ADR 
reporting process might assist healthcare 
professionals in reporting ADRs. Importantly, the 
accomplishing of the online ADR reporting system is 
also recommended. NCC-PvPI have developed a 
superior version of the Android mobile app "ADR 
PvPI" on Sept 29, 2017, which is an enabler for all 
healthcare professionals and consumers to report 
ADRs instantly [36]. 
In conclusion, the multi-faceted educational 
intervention significantly improved the knowledge, 
perceptive behavior, and practice skills scores of 
pharmacovigilance of our Indian pharmacy students. 
Pharmacovigilance can withstand only with the regular 
spontaneous ADR reporting by different health-care 
professionals, including pharmacists, which depends 
on their satisfactory knowledge about PV and their 
compliance with reporting. Therefore, regular 
Continued Medical Education (CME), workshops, 
conferences, post-training reminders like sending e-
mails, SMS alerts should be conducted to facilitate the 
culture of reporting and creating awareness among 
pharmacists. 
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